Key Takeaways
- Nautilus Biotechnology will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026.
- A live and archived webcast of the presentation will be available on Nautilus’ website.
- The company aims to innovate protein analysis to advance human health and medicine.
Nautilus Biotechnology to Present at Health Care Conference
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a leader in single-molecule protein analysis, announced its participation in the TD Cowen 46th Annual Health Care Conference. The company’s management will engage in a fireside chat scheduled for March 2, 2026, at 10:30 a.m. Eastern Time.
The presentation will be accessible via a live webcast, which will also be archived for later viewing. Interested individuals can find the webcast on the “Investors” section of Nautilus’ official website at www.nautilus.bio.
Headquartered in Seattle, Washington, with research and development operations in San Carlos, California, Nautilus is advancing technology dedicated to enhancing the understanding and analysis of the proteome. The company’s mission focuses on democratizing proteomics, making it more accessible, and stimulating key advancements in human health and medicine. Through innovative approaches, Nautilus seeks to redefine the landscape of life sciences using its groundbreaking platform technology.
For more information, visit www.nautilus.bio or contact the media and investor relations teams at the provided email addresses.
The content above is a summary. For more details, see the source article.